Contact this trialFirst, we need to learn more about you.
Chemotherapy
HER2-targeted Therapy + Immunotherapy for Breast Cancer
Recruiting1 awardPhase 2
Portland, Oregon
This trial is testing whether adding the drug pembrolizumab to a standard treatment regimen for HER2-positive breast cancer improves outcomes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service